The International Institute for the Advancement of Medicine (IIAM) Email Format
Research ServicesNew Jersey, United States51-200 Employees
The International Institute for the Advancement of Medicine (IIAM) operates within the research services sector, focusing on providing non-transplantable organs to the medical research community to support studies, therapeutic applications, and pre-clinical investigations targeting a range of metabolic disorders. As a nonprofit with decades of experience, IIAM collaborates with organ procurement organizations and research institutions to source human tissue in a way that honors donor and family wishes while advancing scientific inquiry. The organization is a wholly-owned division of MTF Biologics, a global nonprofit based in Edison, New Jersey, and it emphasizes education of the next generation of researchers to extend the impact of donor contributions. Headquartered in Edison, New Jersey, IIAM maintains partnerships across the United States to facilitate access to non-transplantable organs for research purposes. Its work centers on enabling groundbreaking medical studies and expanding therapeutic options by providing viable tissue for cellular isolation, expansion, and related investigative efforts. Recent activity includes collaboration initiatives and leadership appointments within its regional network, reflecting ongoing efforts to broaden its reach and effectiveness in the organ research ecosystem.